| |
WOUNDTEK, INC ANNOUNCES
NEW DISTRIBUTION AGREEMENT WITH
SURGICAL PRICIPALS OF SEATTLE/TACOMA WASHINGTON
NEWPORT, RI, May 16, 2006
-- WoundTEK, Inc., a privately held medical device company, announced
today that has entered into an exclusive agreement with Surgical
Principals, Inc. to market and distribute it’s leading wound
closure device throughout the West Coast.
The Agreement allows Surgical Principals to exclusively
market and sell the S.T.A.R. device into this vast region. The S.T.A.R.,
(Suture Tension Adjustment Reel) is the first minimally invasive
tissue expansion device for the closure of large open wounds caused
by trauma and surgery.
"I am very optimistic about this relationship.
Having Tim Wynne and the Surgical Principals team represent our
company in this large and critical territory will have a tremendous
impact on our business this year. The team members have been selling
specialty medical products to surgical hospitals in this market
for a very long time and they have over 20 sales people that have
relationships with hundreds of hospitals. It represents a very large
opportunity for us to grow our awareness and our market share rapidly.”
Said Andrew Reilly, WoundTEK, Inc. Chief Executive.
“Surgical Principals has the ability to
create markets for new and innovative surgical products. The opportunity
that the S.T.A.R. device represents is very large and I think that
we can help WoundTEK become a dominant player in the wound closure
space.” Said Tim Wynn, Surgical Principals’ President.
He continued; “We look forward to a long and prosperous relationship
with WoundTEK.”
Surgical Principals, Inc., is a specialty surgical
product distributor founded in September of 2000 by Tim Wynne. Mr.
Wynne has significant experience in surgical sales and distribution.
He founded Horizon Medical Technologies in 1992 and developed it
into a leading specialty surgical products distributor. SPI currently
employs fifteen sales representatives covering the states of AK,
AZ, CA, CO, ID, MT, NM, NV, OR, UT, WA and WY.
WoundTEK, Inc based in Newport, RI is a medical device company focused
on the closure of large wounds and skin deficits caused by trauma
or surgery. The company manufactures the S.T.A.R. device; the first
minimally invasive tissue approximation device. The S.T.A.R. brings
to closure large wounds that cannot be closed using primary closure
methods. Comprised of a winder reel and an anchor mechanism, joined
by a simple mattress suture, the S.T.A.R. is able to rapidly expand
tissue across large skin deficits with very little discomfort, closing
large wounds faster and raising the level of patient care.
Large wound closure is
a major health care problem worldwide and is one of the leading
causes of deadly infections in the United States. Approximately
1,940,000 trauma cases and surgical procedures each year are faced
with the challenge of closing large wounds and skin deficits. Current
procedures to close large wounds can be technically demanding, increase
the risk of infection, and be very invasive, painful, and have deep
scaring effects to the tissue. The STAR System reduces many of the
challenges that are currently faced by surgeons today.
# # #
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are necessarily
estimates reflecting the best judgment of our management and involve
a number of risks and uncertainties that could cause actual results
to differ materially from those suggested by the forward-looking
statements. These forward-looking statements should, therefore,
be considered in light of various important factors, including the
following: timing and success of product development and market
acceptance of developed products; regulatory approvals, clearances
and restrictions; guidelines and recommendations in the health care
and patient communities; intellectual property positions and litigation;
competition in the medical device industry and in the specific markets
of surgery in which WoundTEK operates; unanticipated manufacturing
disruptions, delays in regulatory approvals of new manufacturing
facilities or the inability to meet demand for products. Words such
as "estimate," "project," "plan,"
"intend," "expect," "anticipate,"
"believe" and similar expressions are intended to identify
forward-looking statements. You are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date of this press release. We undertake no obligation to
publicly update or release any revisions to these forward-looking
statements to reflect events or circumstances after the date of
this press release or to reflect the occurrence of unanticipated
events.
|
|